Company Registration No. 07737587 (England and Wales)
Sabal Health and Pharma Ltd
Unaudited accounts
for the year ended 31 December 2016
Sabal Health and Pharma Ltd
Unaudited accounts
Contents
Sabal Health and Pharma Ltd
Company Information
for the year ended 31 December 2016
Directors
T W Goodey
J R Heslin
A J Williams
S R Williams
Company Number
07737587 (England and Wales)
Registered Office
Spa House
69 Southend Road
Hockley
Essex
SS5 4PZ
England
Sabal Health and Pharma Ltd
Statement of financial position
as at 31 December 2016
Cash at bank and in hand
300,077
93,227
Creditors: amounts falling due within one year
(935,994)
(606,145)
Net current assets
351,522
239,640
Net assets
351,720
240,498
Called up share capital
20,000
20,000
Profit and loss account
331,720
220,498
Shareholders' funds
351,720
240,498
For the year ending 31 December 2016 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
Approved by the Board on 15 March 2017.
T W Goodey
Director
Company Registration No. 07737587
Sabal Health and Pharma Ltd
Notes to the Accounts
for the year ended 31 December 2016
Sabal Health and Pharma Ltd is a private company, limited by shares, registered in England and Wales, registration number 07737587. The registered office and principal place of business is Spa House, 69 Southend Road, Hockley, Essex, SS5 4PZ, England.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
These financial statements for the year ended 31 December 2016 are the first financial statements that comply with FRS 102 Section 1A Small Entities. The date of transition is 1 January 2016.
The transition to FRS 102 Section 1A Small Entities has resulted in a small number of changes in accounting policies to those used previously.
The nature of these changes and their impact on opening equity and profit for the comparative period are explained in the notes below.
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
The accounts are presented in £ sterling.
Turnover represents net invoiced sales of goods, excluding value added tax.
Tangible fixed assets policy
Depreciation is provided at the following annual rates in order to write off each assets over its estimated useful life:
Plant & machinery
33% on Cost
Stocks and are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rates of exchange ruling at the date of the transaction. Exchange differences are taken into account in arriving at the operating profit.
Hire Purchase & Leasing Commitments
Rentals paid under operating leases are charged to the profit and loss account on a straight line basis over the period of the lease.
Sabal Health and Pharma Ltd
Notes to the Accounts
for the year ended 31 December 2016
4
Intangible fixed assets
Goodwill
5
Tangible fixed assets
Plant & machinery
Trade debtors
885,453
738,886
Accrued income and prepayments
4,922
-
Other debtors
2,125
13,323
Sabal Health and Pharma Ltd
Notes to the Accounts
for the year ended 31 December 2016
8
Creditors: amounts falling due within one year
2016
2015
Trade creditors
709,486
483,240
Taxes and social security
31,497
15,765
Other creditors
150,424
107,140
Allotted, called up and fully paid:
20,000 Ordinary shares of £1 each
20,000
20,000
10
Operating lease commitments
2016
2015
At 31 December 2016 the company has commitments under non-cancellable operating leases as follows:
Operating leases expiring:
Within two to five years
-
8,500
At the balance sheet date the company owed A J Williams £34,000 in respect of his directors loan account. Interest ispayable at 5% per annum on the outstanding balance.
The company is controlled by A J Williams by virtue of his shareholding.
13
Average number of employees
During the year the average number of employees was 7 (2015: 7).
